Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated 26 minutes ago
Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing
26 minutes ago
The Senate Committee on Health, Education, Labor and Pensions (HELP) today questioned...
Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
about 4 hours ago
Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint...
China’s Henlius carves out $440M T-cell engager deal with Amberstone
about 4 hours ago
Fosun Pharma subsidiary Henlius Biotech has signed a $440 million biobucks deal...
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
about 6 hours ago
Despite a major trial setback earlier this year and increasing questions over...
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
about 7 hours ago
Roche has penned a backloaded $2 billion deal with hematology biotech Atavistik...
Merck sees pivotal victory for $3B eye disease prospect
about 7 hours ago
Merck & Co.’s Brunello trial has hit its primary endpoint, shedding light...
Adagio Medical kicks off strategic review, trims more than half its staff
about 7 hours ago
Adagio Medical has initiated a strategic review of its business and will...
Why a US senator wants a biotech leader in the White House who ‘has the president’s ear’
about 8 hours ago
Senator Todd Young (R-IN), chairman of the National Security Commission on Emerging...
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
about 10 hours ago
As two Big Pharma players in the autoimmune CAR-T space face unexpected...
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with InnoCare
about 12 hours ago
Eli Lilly has committed $100 million in upfront and near-term payments to...
‘It’s actually very radical’: NIH debuts tool to help scientists navigate biomedical database
1 day ago
The NIH’s National Library of Medicine has released the pilot version of...
Enveda reaps $311M series E to feed ambition to become a ‘household name’
1 day ago
Enveda has raised a $311 million series E round, positioning the nature-derived...